Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

HBI 2020: Lessons on reaching the patient

An insurer, an integrated healthcare provider and a telehealth player are three providers with very different experiences of being able to reach the patient. HBI looks at four tangible lessons from Aetna, Medicover and Kry from HBI 2020.
December 22, 2020

HBI 2020: GDPR kills off international competition for genetic tests

GDPR made it much harder to send samples outside Europe for genetic testing, the director for genetics at Europe's largest lab group Synlab told HBI 2020 delegates. He went through the basics of running a genetic lab business, including workforce, payors and the main challenges.
December 21, 2020

HBI 2020: Non-COVID lab volumes recover in Q3 but M&A model may be redundant

Non-COVID lab volumes reached their pre-pandemic levels in Q3. But does the pandemic signal the end of the sector's reliance on M&A, and what are the implications of new B2C markets? Operators Unilabs, amedes, Medicover and Dr Lal Pathlabs, B2C platform Daslab and supplier Abbott discussed all this and more at HBI 2020's 'Diagnostics: Opportunities and Challenges' & 'A new global consumer market?' sessions.
December 21, 2020

HBI 2020: Emerging Markets – local trumps medical tourism

The IFC said at HBI 2020 that medical tourism in emerging markets is unlikely to normalise until the end of 2021. Providers say they are already doubling and tripling plans to build in domestic markets, rather than bringing patients to tourism hubs. 
December 21, 2020

HBI 2020: Data drives Ping An and Teladoc’s global expansion

Ping An and Teladoc revealed their plans for global expansion at HBI 2020. The former says it's hard to leave such a big domestic market as China but has sights set on SE Asia and 'the developing world'. Teladoc is focused on Europe, Brazil and also on Ping An's home turf, China! Both are now capable of delivering full acuity care and have driven their insights using some of healthcare's largest datasets.
December 21, 2020

HBI 2020: The future of domiciliary homecare – meeting an insatiable demand

In many markets there is a growing, perhaps even an insatiable demand for unskilled homecare. Is it a sector where it is possible to make money, and how? Is reimbursement sufficient? How do you attract and retain staff? And what effect is COVID having on the market? An expert panel at HBI 2020 considered all this, together with the biggest risks, and best opportunities, as we all dare to look forward to a more normal life in 2021.
December 21, 2020

HBI 2020: Investor interest in hospitals increases while outpatient valuations drop

Investors from varied backgrounds - infrastructure, private equity, and REIT, are all bullish about the prospects for healthcare investment in 2021, according to a panel of experts speaking at the HBI 2020 European Investment Panel discussion. But the pandemic may have 'readjusted the relative value discussion across sectors' according to one private equity investor.
December 21, 2020
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us